Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

FOLD

Amicus Therapeutics Inc

Apr 26 • 04:00PM ET

10.28

Dollar change +0.11
Percentage change 1.08	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM VBK VXF IWO IBB VTWO SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-0.52	Insider Own	2.98%	Shs Outstand	293.59M	Perf Week	-3.11%
Market Cap	3.04B	Forward P/E	26.52	EPS next Y	0.39	Insider Trans	-5.55%	Shs Float	287.34M	Perf Month	-13.32%
Income	-151.58M	PEG	-	EPS next Q	-0.06	Inst Own	106.31%	Short Float	10.90%	Perf Quarter	-16.69%
Sales	399.36M	P/S	7.62	EPS this Y	98.81%	Inst Trans	-4.29%	Short Ratio	10.21	Perf Half Y	-4.81%
Book/sh	0.55	P/B	18.84	EPS next Y	6481.79%	ROA	-20.18%	Short Interest	31.32M	Perf Year	-11.07%
Cash/sh	0.97	P/C	10.64	EPS next 5Y	-	ROE	-107.04%	52W Range	9.70 - 14.57	Perf YTD	-27.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	22.84%	ROI	-25.39%	52W High	-29.44%	Beta	0.79
Dividend TTM	-	Quick Ratio	2.52	Sales past 5Y	37.81%	Gross Margin	88.68%	52W Low	5.98%	ATR (14)	0.36
Dividend Ex-Date	-	Current Ratio	2.88	EPS Y/Y TTM	37.05%	Oper. Margin	-18.40%	RSI (14)	33.84	Volatility	2.79% 2.84%
Employees	517	Debt/Eq	2.78	Sales Y/Y TTM	21.30%	Profit Margin	-37.96%	Recom	1.55	Target Price	18.78
Option/Short	Yes / Yes	LT Debt/Eq	2.73	EPS Q/Q	41.97%	Payout	-	Rel Volume	0.56	Prev Close	10.17
Sales Surprise	0.64%	EPS Surprise	-90.31%	Sales Q/Q	30.63%	Earnings	Feb 28 BMO	Avg Volume	3.07M	Price	10.28
SMA20	-6.93%	SMA50	-14.18%	SMA200	-15.90%	Trades		Volume	1,714,609	Change	1.08%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$15 → $20
Sep-09-22	Initiated	Morgan Stanley	Equal-Weight	$14
Apr-13-22	Resumed	Goldman	Neutral	$11
Jan-14-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$12 → $16
Nov-15-21	Upgrade	Stifel	Hold → Buy	$12 → $16
Sep-30-21	Upgrade	JP Morgan	Neutral → Overweight	$16
Jul-19-21	Resumed	BTIG Research	Buy	$15
May-27-21	Initiated	Needham	Hold
May-21-21	Initiated	UBS	Buy	$16
Apr-14-21	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$17
Mar-02-21	Initiated	Stifel	Hold	$13
Feb-12-21	Downgrade	JP Morgan	Overweight → Neutral	$19
Feb-12-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$30 → $17
Dec-28-20	Resumed	Cantor Fitzgerald	Overweight	$20 → $30
Dec-10-20	Downgrade	Citigroup	Buy → Neutral	$20 → $27
Nov-11-20	Initiated	Berenberg	Hold
Jun-17-20	Initiated	BTIG Research	Buy	$19
Feb-04-20	Resumed	Cantor Fitzgerald	Overweight	$19 → $20
Nov-12-19	Reiterated	H.C. Wainwright	Buy	$18 → $20
Jun-17-19	Initiated	H.C. Wainwright	Buy	$18

Show Previous Ratings

Mar-29-24 11:30AM	Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? (Zacks)
Mar-26-24 09:53AM	WuXi Biologics Reports Solid 2023 Annual Results (PR Newswire)
Mar-20-24 07:00AM	Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Mar-13-24 07:07AM	13 Best Biotech Stocks To Buy Under $20 (Insider Monkey)
Mar-06-24 11:56PM	Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) (GuruFocus.com) -5.62%
01:50PM	Loading…
Mar-05-24 01:50PM	Amicus Therapeutics Stock Sees RS Rating Improve To 74 (Investor's Business Daily)
Mar-01-24 07:00AM	Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 (GlobeNewswire)
Feb-29-24 11:25AM	Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:23AM	Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates (Zacks)
Feb-28-24 11:49PM	Q4 2023 Amicus Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -6.50%
08:20AM	Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:32AM	Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ... (GuruFocus.com)
07:00AM	Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-15-24 07:00AM	Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire) +6.22%
Feb-09-24 03:14PM	Amicus Therapeutics Stock Sees Improved Relative Strength Rating (Investor's Business Daily)
07:00AM	Loading…
Feb-08-24 07:00AM	Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) at the 20th Annual WORLDSymposium (GlobeNewswire)
Feb-01-24 07:00AM	Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium 2024 (GlobeNewswire)
Jan-12-24 11:02PM	Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares (GuruFocus.com)
09:31AM	Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why (Zacks)
Jan-08-24 09:40AM	Amicus (FOLD) Issues Preliminary Revenue Results for FY23 (Zacks)
Jan-07-24 04:00PM	Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook (GlobeNewswire)
Jan-05-24 07:02PM	Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 15,833 Shares (GuruFocus.com)
Jan-03-24 11:46AM	15 Best Growth Stocks to Buy Under $25 (Insider Monkey)
07:00AM	Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-30-23 09:01AM	Amicus Therapeutics Inc's Chief Development Officer Sells Shares (GuruFocus.com)
Dec-29-23 09:48AM	Amicus (FOLD) Banks on Galafold, Overdependence a Concern (Zacks)
07:01AM	Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares (GuruFocus.com)
Dec-24-23 06:17AM	Time to Pull the Trigger, Says Morgan Stanley About These 2 Healthcare Stocks (TipRanks)
Dec-21-23 05:01AM	Amicus Therapeutics Inc's Chief Development Officer Sells Shares (GuruFocus.com)
Dec-08-23 11:30AM	Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report? (Zacks)
06:38AM	Loading…
Dec-05-23 06:38AM	BIO names longtime Amicus head John Crowley as new CEO (BioPharma Dive)
06:00AM	Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO (GlobeNewswire)
05:30AM	He Designed Drugs to Save His Children. Now Hes Working to Save Biotech, Too. (The Wall Street Journal)
Nov-15-23 09:48AM	7 Stocks Most Likely to Follow in WeWorks Woeful Footsteps (InvestorPlace)
Nov-10-23 10:07AM	Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 01:02PM	Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated (Zacks) -12.19%
Nov-08-23 07:13AM	Amicus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates (GlobeNewswire)
Nov-04-23 05:03AM	Insider Sell: Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 11,700 Shares (GuruFocus.com)
Nov-02-23 10:00AM	Synlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Nov-01-23 10:01AM	Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:00AM	Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023 (GlobeNewswire)
Oct-27-23 07:00AM	Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023 (GlobeNewswire)
Oct-08-23 07:00AM	This Rare Disease Pharma Is a Hidden Gem (TheStreet.com)
Oct-05-23 07:45PM	Stay Invested Through the Uncertainty: J.P. Morgan Says Stocks Could Reach New Highs Next Year Here Are 2 Names to Pounce on Now (TipRanks)
03:01AM	Insider Sell: Amicus Therapeutics Inc President & CEO Bradley Campbell Sells 11,700 Shares (GuruFocus.com)
Oct-03-23 07:00AM	Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023 (GlobeNewswire)
Oct-02-23 08:20AM	Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration (GlobeNewswire) -9.29%
Oct-01-23 08:30PM	WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease (PR Newswire)
Sep-29-23 12:22PM	Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023 (Associated Press Finance)
09:09AM	Amicus (FOLD) Gets FDA Approval for Pompe Disease Drug (Zacks)
Sep-28-23 11:08AM	UPDATE 1-US FDA approves Amicus Therapeutics' muscle disorder treatment (Reuters) -7.92%
10:50AM	U.S. FDA approves Amicus Therapeutics' muscle disorder treatment (Reuters)
10:41AM	Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease (GlobeNewswire)
10:32AM	Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark (Investor's Business Daily)
Sep-21-23 08:42AM	Zacks.com featured highlights include Amicus Therapeutics, Genius Sports and Viad (Zacks)
Sep-07-23 11:30AM	Why Is Amicus Therapeutics (FOLD) Down 6.8% Since Last Earnings Report? (Zacks)
Sep-01-23 07:00AM	Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023 (GlobeNewswire)
Aug-29-23 07:00AM	Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023 (GlobeNewswire)
Aug-21-23 07:00AM	Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer (GlobeNewswire)
Aug-15-23 07:00AM	Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom (GlobeNewswire)
Aug-09-23 09:25AM	Amicus (FOLD) Misses on Q2 Earnings, Raises Revenue Guidance (Zacks)
Aug-08-23 08:40AM	Amicus Therapeutics (FOLD) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +10.53%
07:29AM	Amicus Therapeutics: Q2 Earnings Snapshot (AP Finance)
07:00AM	Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates (GlobeNewswire)
Aug-07-23 08:48AM	Why Earnings Season Could Be Great for Amicus Therapeutics (FOLD) (Zacks)
Aug-04-23 08:05AM	Zacks.com featured highlights include First Watch Restaurant Group, VersaBank and Amicus Therapeutics (Zacks)
Jul-31-23 07:00AM	Amicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jul-23-23 10:23AM	Amicus Therapeutics' (NASDAQ:FOLD) investors will be pleased with their favorable 33% return over the last year (Simply Wall St.)
Jul-20-23 02:24PM	Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade (Investor's Business Daily)
Jul-17-23 01:54PM	Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating (Investor's Business Daily)
Jun-28-23 10:53AM	Amicus (FOLD) Gets Approval in Europe for Pompe Disease Drug (Zacks)
Jun-27-23 07:00AM	Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union (GlobeNewswire)
Jun-09-23 11:30AM	Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report? (Zacks)
Jun-04-23 09:59AM	Amicus Therapeutics, Inc. (NASDAQ:FOLD): Is Breakeven Near? (Simply Wall St.)
May-11-23 07:44AM	Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow (Zacks)
May-10-23 08:15AM	Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.00%
07:10AM	Amicus Therapeutics: Q1 Earnings Snapshot (AP Finance)
07:00AM	Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates (GlobeNewswire)
May-08-23 10:00AM	Icosavax, Inc. (ICVX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
May-02-23 07:00AM	Amicus Therapeutics to Present at the Bank of America 2023 Health Care Conference (GlobeNewswire)
May-01-23 10:01AM	Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know (Zacks)
07:00AM	Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023 (GlobeNewswire)
Apr-26-23 01:00PM	Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease (GlobeNewswire)
Apr-18-23 09:20AM	Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Popularity With Investors Is Under Threat From Overpricing (Simply Wall St.)
Apr-14-23 02:45PM	The FDA Is Resuming Drug Lab Inspections in China. These Biotechs Could Benefit. (Barrons.com)
Mar-31-23 11:30AM	Amicus Therapeutics (FOLD) Down 14% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-27-23 07:00AM	Amicus Therapeutics Announces European Commission Approval for Pombiliti in Patients with Late-Onset Pompe Disease (GlobeNewswire)
Mar-08-23 07:00AM	Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-02-23 11:39AM	Amicus (FOLD) Q4 Earnings Miss, Galafold Sales Beat Estimates (Zacks) -6.35%
04:28AM	Q4 2022 Amicus Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-01-23 09:35AM	Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates (GlobeNewswire)
Feb-27-23 07:00AM	Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-22-23 05:00PM	Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium 2023 (GlobeNewswire)
Feb-14-23 07:00AM	Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023 (GlobeNewswire)
Feb-13-23 07:00AM	Amicus Therapeutics Announces Presentations and Posters at the 19th Annual WORLDSymposium 2023 (GlobeNewswire)
Feb-12-23 07:33AM	Swelling losses haven't held back gains for Amicus Therapeutics (NASDAQ:FOLD) shareholders since they're up 39% over 1 year (Simply Wall St.)
Feb-08-23 07:00AM	Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-01-23 09:43AM	Strength Seen in Syros Pharmaceuticals, Inc. (SYRS): Can Its 5.4% Jump Turn into More Strength? (Zacks)

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Campbell Bradley L	President and CEO	Apr 01 '24	Option Exercise	8.61	7,500	64,575	894,154	Apr 03 06:14 PM
Campbell Bradley L	President and CEO	Apr 01 '24	Sale	11.67	7,500	87,496	886,654	Apr 03 06:14 PM
SBLENDORIO GLENN	Director	Mar 07 '24	Option Exercise	2.80	15,000	42,000	83,596	Mar 11 05:36 PM
RAAB MICHAEL	Director	Mar 05 '24	Option Exercise	2.80	15,000	42,000	83,596	Mar 06 05:22 PM
MCGLYNN MARGARET G	Director	Mar 05 '24	Option Exercise	2.80	7,500	21,000	66,789	Mar 06 05:21 PM
MCGLYNN MARGARET G	Director	Mar 05 '24	Sale	13.40	7,500	100,500	59,289	Mar 06 05:21 PM
MCGLYNN MARGARET G	Director	Mar 04 '24	Option Exercise	2.80	7,500	21,000	66,789	Mar 06 05:21 PM
MCGLYNN MARGARET G	Director	Mar 04 '24	Sale	13.29	7,500	99,675	59,289	Mar 06 05:21 PM
Campbell Bradley L	President and CEO	Mar 01 '24	Option Exercise	10.54	15,833	166,904	887,052	Mar 05 05:14 PM
Crowley John F	Executive Chairman	Mar 01 '24	Sale	13.35	29,181	389,543	573,478	Mar 05 05:14 PM
Campbell Bradley L	President and CEO	Mar 01 '24	Sale	13.14	15,833	208,017	871,219	Mar 05 05:14 PM
Crowley John F	Executive Chairman	Feb 15 '24	Sale	13.81	31,614	436,551	697,628	Feb 20 05:23 PM
Clark David Michael	Chief People Officer	Feb 15 '24	Sale	14.00	4,427	61,978	253,664	Feb 20 05:20 PM
Campbell Bradley L	President and CEO	Feb 15 '24	Sale	14.00	4,167	58,338	871,219	Feb 20 05:21 PM
Rosenberg Ellen	Chief Legal Officer	Feb 07 '24	Option Exercise	5.16	29,600	152,736	397,254	Feb 08 04:40 PM
Rosenberg Ellen	Chief Legal Officer	Feb 07 '24	Sale	13.00	29,600	384,818	367,654	Feb 08 04:40 PM
Rosenberg Ellen	Chief Legal Officer	Feb 06 '24	Option Exercise	5.16	400	2,064	368,054	Feb 08 04:40 PM
Rosenberg Ellen	Chief Legal Officer	Feb 06 '24	Sale	13.00	400	5,200	367,654	Feb 08 04:40 PM
Campbell Bradley L	President and CEO	Feb 01 '24	Option Exercise	10.54	15,833	166,904	891,219	Feb 05 07:22 PM
Crowley John F	Executive Chairman	Feb 01 '24	Sale	12.62	31,614	398,918	750,838	Feb 05 07:22 PM
Campbell Bradley L	President and CEO	Feb 01 '24	Sale	12.56	15,833	198,858	875,386	Feb 05 07:22 PM
Crowley John F	Executive Chairman	Jan 22 '24	Sale	12.36	55,327	683,958	782,452	Jan 24 05:20 PM
Crowley John F	Executive Chairman	Jan 16 '24	Sale	12.78	31,614	404,106	837,779	Jan 18 05:09 PM
Crowley John F	Executive Chairman	Jan 10 '24	Sale	13.65	31,614	431,452	869,393	Jan 11 06:33 PM
Clark David Michael	Chief People Officer	Jan 09 '24	Sale	14.00	1,384	19,376	266,705	Jan 09 06:08 PM
Prout Samantha	Chief Accounting Officer	Jan 09 '24	Sale	14.00	1,337	18,718	80,953	Jan 09 06:07 PM
Prout Samantha	Chief Accounting Officer	Jan 08 '24	Sale	14.00	30,767	430,827	82,290	Jan 09 06:07 PM
Clark David Michael	Chief People Officer	Jan 08 '24	Sale	14.00	8,726	122,164	268,089	Jan 09 06:08 PM
Campbell Bradley L	President and CEO	Jan 02 '24	Option Exercise	10.54	15,833	166,904	956,138	Jan 04 06:35 PM
Rosenberg Ellen	Chief Legal Officer	Jan 02 '24	Option Exercise	5.16	30,000	154,800	372,285	Jan 04 06:24 PM
Rosenberg Ellen	Chief Legal Officer	Jan 02 '24	Sale	14.21	30,000	426,219	342,285	Jan 04 06:24 PM
Campbell Bradley L	President and CEO	Jan 02 '24	Sale	14.23	15,833	225,380	947,805	Jan 04 06:35 PM
Castelli Jeff	Chief Development Officer	Dec 28 '23	Sale	14.52	17,421	252,902	340,661	Dec 29 05:18 PM
Rosenberg Ellen	Chief Legal Officer	Dec 27 '23	Option Exercise	5.16	5,000	25,800	347,285	Dec 28 05:08 PM
Rosenberg Ellen	Chief Legal Officer	Dec 27 '23	Sale	14.07	5,000	70,327	342,285	Dec 28 05:08 PM
Rosenberg Ellen	Chief Legal Officer	Dec 26 '23	Option Exercise	5.16	30,000	154,800	372,285	Dec 28 05:08 PM
Rosenberg Ellen	Chief Legal Officer	Dec 26 '23	Sale	14.00	30,000	420,084	342,285	Dec 28 05:08 PM
Prout Samantha	Chief Accounting Officer	Dec 26 '23	Sale	14.00	7,659	107,228	121,912	Dec 28 05:09 PM
Castelli Jeff	Chief Development Officer	Dec 20 '23	Sale	13.10	1,654	21,667	358,082	Dec 20 04:41 PM
Castelli Jeff	Chief Development Officer	Dec 19 '23	Sale	13.25	17,500	231,875	359,736	Dec 20 04:41 PM
Crowley John F	Executive Chairman	Dec 15 '23	Sale	12.66	6,043	76,516	877,748	Dec 19 05:55 PM
Campbell Bradley L	President and CEO	Dec 01 '23	Option Exercise	2.94	11,702	34,404	803,863	Dec 05 05:07 PM
Campbell Bradley L	President and CEO	Dec 01 '23	Sale	11.08	11,702	129,693	792,161	Dec 05 05:07 PM
Crowley John F	Executive Chairman	Dec 01 '23	Sale	11.08	6,043	66,956	883,791	Dec 05 05:03 PM
Crowley John F	Executive Chairman	Nov 15 '23	Sale	10.84	6,043	65,497	889,834	Nov 17 05:23 PM
Campbell Bradley L	President and CEO	Nov 01 '23	Option Exercise	2.94	11,700	34,398	803,861	Nov 03 07:38 PM
Campbell Bradley L	President and CEO	Nov 01 '23	Sale	10.97	11,700	128,391	792,161	Nov 03 07:38 PM
Crowley John F	Executive Chairman	Nov 01 '23	Sale	10.97	6,044	66,327	895,877	Nov 03 07:37 PM
Crowley John F	Executive Chairman	Oct 16 '23	Sale	10.50	6,044	63,449	901,921	Oct 18 07:57 PM
Campbell Bradley L	President & CEO	Oct 02 '23	Option Exercise	2.94	11,700	34,398	803,861	Oct 04 06:57 PM
Campbell Bradley L	President & CEO	Oct 02 '23	Sale	11.24	11,700	131,489	792,161	Oct 04 06:57 PM
Crowley John F	Executive Chairman	Oct 02 '23	Sale	11.25	6,044	67,967	907,965	Oct 04 06:58 PM
Crowley John F	Executive Chairman	Sep 15 '23	Sale	13.06	6,044	78,964	914,009	Sep 18 05:09 PM
Campbell Bradley L	President & CEO	Sep 01 '23	Option Exercise	2.94	11,700	34,398	810,254	Sep 06 05:29 PM
Campbell Bradley L	President & CEO	Sep 01 '23	Sale	12.97	18,093	234,648	792,161	Sep 06 05:29 PM
Crowley John F	Executive Chairman	Sep 01 '23	Sale	12.98	6,044	78,447	920,053	Sep 06 05:31 PM
Crowley John F	Executive Chairman	Aug 15 '23	Sale	13.03	6,044	78,734	926,097	Aug 16 05:33 PM
Prout Samantha	Chief Accounting Officer	Aug 09 '23	Option Exercise	11.03	36,909	407,116	173,912	Aug 11 05:28 PM
Prout Samantha	Chief Accounting Officer	Aug 09 '23	Sale	14.01	36,909	516,933	137,003	Aug 11 05:28 PM
Campbell Bradley L	President & CEO	Aug 01 '23	Option Exercise	2.94	11,700	34,398	818,554	Aug 03 05:09 PM
Campbell Bradley L	President & CEO	Aug 01 '23	Sale	13.39	20,000	267,874	798,554	Aug 03 05:09 PM
Crowley John F	Executive Chairman	Aug 01 '23	Sale	13.35	6,044	80,716	932,141	Aug 03 05:10 PM
Crowley John F	Executive Chairman	Jul 17 '23	Sale	13.45	6,044	81,263	938,185	Jul 19 05:45 PM
Campbell Bradley L	President & CEO	Jul 13 '23	Sale	12.51	6,800	85,091	806,854	Jul 14 05:06 PM
Campbell Bradley L	President & CEO	Jul 12 '23	Sale	12.51	1,500	18,759	813,654	Jul 14 05:06 PM
Campbell Bradley L	President & CEO	Jul 03 '23	Option Exercise	2.94	11,700	34,398	826,854	Jul 06 06:25 PM
Campbell Bradley L	President & CEO	Jul 03 '23	Sale	12.31	11,700	144,016	815,154	Jul 06 06:25 PM
Crowley John F	Executive Chairman	Jul 03 '23	Sale	12.31	6,044	74,406	944,229	Jul 06 06:26 PM
Crowley John F	Executive Chairman	Jun 15 '23	Sale	13.04	6,044	78,814	950,273	Jun 20 05:18 PM
Campbell Bradley L	President & CEO	Jun 06 '23	Sale	12.50	8,300	103,777	815,154	Jun 08 05:26 PM
Campbell Bradley L	President & CEO	Jun 01 '23	Option Exercise	2.64	11,700	30,907	835,154	Jun 05 07:16 PM
Campbell Bradley L	President & CEO	Jun 01 '23	Sale	11.36	11,700	132,942	823,454	Jun 05 07:16 PM
Crowley John F	Executive Chairman	Jun 01 '23	Sale	11.36	6,044	68,657	956,317	Jun 05 07:16 PM
SBLENDORIO GLENN	Director	May 18 '23	Option Exercise	3.32	15,000	49,800	86,719	May 19 05:13 PM
Crowley John F	Executive Chairman	May 15 '23	Sale	11.18	6,044	67,577	962,361	May 17 06:20 PM
Campbell Bradley L	President & CEO	May 01 '23	Option Exercise	2.45	11,700	28,665	835,154	May 03 04:31 PM
Campbell Bradley L	President & CEO	May 01 '23	Sale	11.80	11,700	138,093	823,454	May 03 04:31 PM
Crowley John F	Executive Chairman	May 01 '23	Sale	11.80	6,044	71,335	968,405	May 03 04:35 PM

Open in Screener

RH

Apr 26 • 04:00PM ET

248.91

Dollar change +5.54
Percentage change 2.28	%

Consumer Cyclical • Specialty Retail • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IJH VXF VBK IJJ IWR IJK OMFL SCHM

Index	-	P/E	44.60	EPS (ttm)	5.58	Insider Own	19.10%	Shs Outstand	18.32M	Perf Week	3.54%
Market Cap	4.56B	Forward P/E	16.84	EPS next Y	14.78	Insider Trans	-2.49%	Shs Float	14.86M	Perf Month	-16.19%
Income	127.56M	PEG	178.40	EPS next Q	-0.18	Inst Own	88.40%	Short Float	14.58%	Perf Quarter	-8.70%
Sales	3.03B	P/S	1.51	EPS this Y	29.70%	Inst Trans	1.18%	Short Ratio	2.97	Perf Half Y	10.03%
Book/sh	-16.24	P/B	-	EPS next Y	65.87%	ROA	2.70%	Short Interest	2.17M	Perf Year	1.51%
Cash/sh	6.75	P/C	36.87	EPS next 5Y	0.25%	ROE	52.36%	52W Range	207.26 - 406.38	Perf YTD	-14.60%
Dividend Est.	-	P/FCF	-	EPS past 5Y	2.91%	ROI	3.92%	52W High	-38.75%	Beta	2.54
Dividend TTM	-	Quick Ratio	0.34	Sales past 5Y	5.02%	Gross Margin	45.86%	52W Low	20.10%	ATR (14)	12.75
Dividend Ex-Date	-	Current Ratio	1.23	EPS Y/Y TTM	-73.25%	Oper. Margin	12.55%	RSI (14)	42.68	Volatility	3.45% 4.48%
Employees	5960	Debt/Eq	-	Sales Y/Y TTM	-15.63%	Profit Margin	4.21%	Recom	2.45	Target Price	334.24
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-86.41%	Payout	0.00%	Rel Volume	0.66	Prev Close	243.37
Sales Surprise	-5.05%	EPS Surprise	-56.80%	Sales Q/Q	-4.43%	Earnings	Mar 27 AMC	Avg Volume	728.66K	Price	248.91
SMA20	-8.05%	SMA50	-9.46%	SMA200	-13.92%	Trades		Volume	478,491	Change	2.28%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-24	Reiterated	Telsey Advisory Group	Market Perform	$285 → $335
Dec-08-23	Reiterated	Telsey Advisory Group	Market Perform	$325 → $285
Dec-05-23	Reiterated	Telsey Advisory Group	Market Perform	$365 → $325
Jun-29-23	Downgrade	Loop Capital	Buy → Hold	$300
Mar-06-23	Downgrade	Jefferies	Buy → Hold	$298
Feb-06-23	Downgrade	Telsey Advisory Group	Outperform → Market Perform	$330
Feb-06-23	Downgrade	Telsey Advisory Group	Outperform → Market Perform	$310 → $330
Dec-12-22	Downgrade	Goldman	Neutral → Sell	$227 → $215
Dec-09-22	Reiterated	Telsey Advisory Group	Outperform	$315 → $310
Nov-21-22	Downgrade	Barclays	Overweight → Equal Weight	$328 → $243
Nov-18-22	Downgrade	Wedbush	Outperform → Neutral	$274 → $270
Sep-21-22	Resumed	William Blair	Outperform	$28 → $21
Jun-30-22	Reiterated	Telsey Advisory Group	Outperform	$375 → $285
May-16-22	Initiated	Morgan Stanley	Equal-Weight	$400
Mar-30-22	Upgrade	Jefferies	Hold → Buy	$634 → $560
Jun-10-21	Upgrade	Gordon Haskett	Hold → Accumulate
Mar-26-21	Upgrade	Jefferies	Underperform → Hold	$335 → $500
Mar-25-21	Reiterated	Telsey Advisory Group	Outperform	$550 → $600
Mar-09-21	Initiated	Citigroup	Buy	$560
Jan-19-21	Reiterated	Guggenheim	Buy	$525 → $650

Show Previous Ratings

Apr-26-24 11:30AM	Why Is RH (RH) Down 30.1% Since Last Earnings Report? (Zacks)
Apr-19-24 04:37AM	Home Furniture Retailer Stocks Q4 Results: Benchmarking RH (NYSE:RH) (StockStory)
Apr-04-24 02:57PM	Why RH Stock Was Sliding This Week (Motley Fool) -5.24%
Apr-02-24 10:47AM	RH (NYSE:RH) Q4 2023 Earnings Call Transcript (Insider Monkey) -7.22%
Apr-01-24 07:07AM	RH Stock Just Popped. 3 Reasons the Growth Stock Can Keep Gaining From Here (Motley Fool)
03:55AM	Loading…
03:55AM	Heard on the Street Recap: Great Quarter, Guys! (The Wall Street Journal)
Mar-30-24 10:47AM	3 No-Brainer Stocks to Buy Right Now With $1,000 and Hold Forever (Motley Fool)
Mar-29-24 05:13PM	RH details 2024 growth on heels of disappointing year (Chain Store Age)
Mar-28-24 04:37PM	S&P 500 Rises to New Record to Close Out Monster First Quarter (The Wall Street Journal) +17.26%
02:11PM	Top Stock Movers Now: Estee Lauder, AMC, RH, and More (Investopedia)
02:07PM	Stocks to Watch Thursday: RH, Walgreens, AMC (The Wall Street Journal)
01:24PM	Sam Bankman-Fried sentenced to 25 years in prison, AMC slumps on stock sale: Yahoo Finance Live (Yahoo Finance Video)
12:36PM	RH (RH) Stock Trades Up, Here Is Why (StockStory)
11:40AM	Why RH Stock Popped Today (Motley Fool)
10:07AM	RH up on strong sales outlook despite rocky housing market (Yahoo Finance Video)
07:30AM	Loading…
07:30AM	Sam Bankman-Fried sentence, Home Depot buys SRS Distribution: Yahoo Finance Live (Yahoo Finance Video)
07:29AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Mar-27-24 10:33PM	RH Stock Pops After Retailer's Product Transformation Overshadows Earnings Miss (Investopedia)
09:53PM	RH Stock Earnings: RH Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:35PM	RH shares pop on Q4 earnings as the company expects accelerated demand (CNBC TV)
05:35PM	RH (RH) Misses Q4 Earnings and Revenue Estimates (Zacks)
05:29PM	RH stock rises despite Q4 revenue miss (Yahoo Finance Video)
04:35PM	Three-Stock Lunch: Tesla, Merck, and RH (CNBC TV)
04:18PM	RH (NYSE:RH) Reports Sales Below Analyst Estimates In Q4 Earnings (StockStory)
04:05PM	RH Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
Mar-26-24 03:00AM	RH (RH) Q4 Earnings: What To Expect (StockStory)
Mar-25-24 09:15AM	Stay Ahead of the Game With RH (RH) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Mar-22-24 06:45AM	RH to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 27, 2024 (Business Wire)
Mar-21-24 03:00AM	This Home-Furnishings Retailers Stock Could Pop After Earnings (Barrons.com) +7.35%
Mar-17-24 07:00AM	Williams-Sonoma Stock Just Soared. Should You Buy This Peer Retail Stock Before April? (Motley Fool)
12:20PM	Loading…
Mar-04-24 12:20PM	11 Best Consumer Electronics Stocks To Buy (Insider Monkey)
09:35AM	Analyst Report: RH (Morningstar Research)
Feb-13-24 12:10PM	RH Unveils the Most Comprehensive Collection of New Outdoor Products in the Brands History (Business Wire) -5.00%
Feb-05-24 04:32PM	Williams-Sonoma has the edge in the retail sector: Analyst (Yahoo Finance Video)
Feb-01-24 04:30AM	Bear of the Day: RH (RH) (Zacks)
Jan-24-24 04:41PM	RH is the 'Costco opposite,' analyst explains (Yahoo Finance Video)
Jan-19-24 12:41AM	Q3 Earnings Highs And Lows: RH (NYSE:RH) Vs The Rest Of The Home Furniture Retailer Stocks (StockStory)
Jan-18-24 08:32AM	RH Announces the Appointment of Jarrett Stuhl as Chief Real Estate & Development Officer (Business Wire)
Dec-23-23 09:01AM	Director Keith Belling Sells 500 Shares of RH (GuruFocus.com)
Dec-19-23 09:17PM	Star-studded center gets set to open in Oklahoma City (Chain Store Age)
04:00AM	Bear of the Day: RH (RH) (Zacks)
Dec-18-23 04:21PM	14 restaurant industry predictions for 2024 from NRN and RH editors (Nation's Restaurant News)
Dec-13-23 06:44PM	Analyst Report: RH (Morningstar Research) +12.15%
Dec-11-23 04:15PM	3 Retail Stocks to Sell as Consumers Tighten Their Belts (InvestorPlace)
10:53AM	Analyst Report: RH (Morningstar Research)
Dec-08-23 06:49PM	Analyst Report: RH (Morningstar Research) -14.00%
01:36PM	FDA approves first CRISPR gene-editing therapy, Lululemon stock rises: Yahoo Finance Live (Yahoo Finance Video)
01:10PM	RH: luxury furniture retailer seeks growth not profit (Financial Times)
12:21PM	RH Stock Falls Victim to High Mortgage Rates (Investopedia)
12:09PM	RH Just Issued a Major Housing Market Warning (InvestorPlace)
11:53AM	Why RH (RH) Stock Is Nosediving (StockStory)
11:48AM	Why RH Stock Crumbled Friday (Motley Fool)
09:06AM	RH (NYSE:RH) Q3 2023 Earnings Call Transcript (Insider Monkey)
Dec-07-23 09:54PM	RH Stock Earnings: RH Misses EPS, Misses Revenue for Q3 2023 (InvestorPlace)
07:08PM	RH Stock Drops On Q3 Performance: Here's Why (Benzinga)
05:51PM	DocuSign earnings top estimates, RH posts unexpected loss (Yahoo Finance Video)
04:41PM	RH (NYSE:RH) Reports Sales Below Analyst Estimates In Q3 Earnings, Stock Drops (StockStory)
04:05PM	RH Reports Third Quarter 2023 Results (Business Wire)
Dec-06-23 02:01AM	RH (RH) Q3 Earnings: What To Expect (StockStory)
Nov-30-23 04:05PM	RH to Report Third Quarter Fiscal 2023 Financial Results on December 7, 2023 (Business Wire)
Nov-22-23 06:34PM	Analyst Report: RH (Morningstar Research)
Nov-20-23 06:41PM	RH opens on 151-acre estate in Indiana (Chain Store Age)
09:17AM	RH Announces the Opening of RH Indianapolis, the Gallery at the DeHaan Estate (Business Wire)
Nov-15-23 08:25AM	Is RH Stock Ready to Make Investors Richer? (Motley Fool)
Nov-14-23 01:15PM	RH Unveils Its First Champagne & Caviar Bar at RH Guesthouse New York (Business Wire) +7.82%
12:10PM	Will RH (RH) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Nov-07-23 07:35AM	5 Best High Beta Stocks to Buy Now (Insider Monkey)
Nov-05-23 08:00AM	All Stores Want for Christmas Is the Right Amount of Stuff (The Wall Street Journal)
Oct-20-23 10:50AM	Spotting Winners: Williams-Sonoma (NYSE:WSM) And Home Furniture Retailer Stocks In Q2 (StockStory)
Oct-18-23 05:03PM	Q2 Rundown: Sleep Number (NASDAQ:SNBR) Vs Other Home Furniture Retailer Stocks (StockStory)
09:26AM	Unpacking Q2 Earnings: Arhaus (NASDAQ:ARHS) In The Context Of Other Home Furniture Retailer Stocks (StockStory)
Oct-17-23 05:51PM	Reflecting On Home Furnishing and Improvement Retail Stocks Q2 Earnings: Home Depot (NYSE:HD) (StockStory)
Oct-16-23 04:43PM	16 Most Expensive Furniture Brands in the World (Insider Monkey)
Oct-14-23 07:20AM	1 Beaten Down Growth Stock to Buy, and 1 to Avoid (Motley Fool)
Oct-07-23 07:43AM	Where Will RH Stock Be in 3 Years? (Motley Fool)
Oct-06-23 08:31AM	Where Will RH Stock Be in 1 Year? (Motley Fool)
Oct-04-23 06:30PM	Analyst Report: RH (Morningstar Research)
Oct-02-23 08:00AM	3 Stocks to Avoid This Week (Motley Fool)
Sep-26-23 03:07PM	RH Provides an Update Regarding the Proposal to Reimagine and Restore One Ocean Drive Miami Beach (Business Wire)
Sep-16-23 08:00AM	3 Top Growth Stocks Down 57% to 83% That You'll Regret Not Buying on the Dip (Motley Fool)
Sep-14-23 01:12PM	Director Carlos Alberini Sells 25,000 Shares of RH (GuruFocus.com)
07:05AM	This Luxury Brand Just Repurchased Almost 20% of Its Stock: Genius or Risky? (Motley Fool)
06:35AM	Berkshire Hathaway Sold More Than 2 Million Shares of RH. You'll Never Believe What Company Just Bought All Those Shares and More. (Motley Fool)
Sep-12-23 12:46PM	Analyst Report: RH (Morningstar Research)
Sep-11-23 05:04PM	Lower-income consumer spending has held up despite rising delinquencies, Goldman Sachs says (Yahoo Finance)
10:41AM	1 Stock That Could Soar When the Housing Market Recovers (Motley Fool)
Sep-08-23 04:30PM	Block outages, Kroger sells stores, RH outlook: Trending Tickers (Yahoo Finance Video) -15.63%
02:33PM	RH stock sinks 15% after CEO warns of 'challenging' luxury housing market (Yahoo Finance)
01:28PM	RH Warns High Mortgage Rates Will Crimp Luxury Home Market, Hurt Furniture Sales (Investopedia)
12:01PM	Why RH Stock Is Down Today (Motley Fool)
10:17AM	RH stock sinks after CEO warns of impact from housing (Yahoo Finance Video)
09:12AM	RH (NYSE:RH) Q2 2023 Earnings Call Transcript (Insider Monkey)
09:03AM	RH (RH) Q2 2023 Earnings: Strong Performance and Optimistic Outlook (GuruFocus.com)
07:23AM	5 Things to Know Before Markets Open (Investopedia)
06:50AM	Home furnishings group RH's full-year outlook misses estimates, shares slump (Investing.com)
Sep-07-23 10:49PM	Analyst Report: RH (Morningstar Research)
05:11PM	DocuSign and RH earnings: After-hours movers (Yahoo Finance Video)
04:05PM	RH Reports Second Quarter 2023 Results (Business Wire)
Sep-06-23 06:33PM	Global design and hospitality brand reveals plans for Miami Beach club property (American City Business Journals)
05:14PM	Jobless claims, Fed comments, earnings: What to watch (Yahoo Finance Video)

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DEMILIO MARK S	Director	Apr 09 '24	Sale	288.99	1,000	288,993	11,991	Apr 11 08:30 PM
DEMILIO MARK S	Director	Apr 02 '24	Sale	308.22	2,000	616,440	12,991	Apr 04 08:30 PM
Lee Edward T	SEE REMARKS	Jan 04 '24	Sale	264.50	2,624	694,058	0	Jan 05 07:30 PM
Belling Keith	Director	Dec 20 '23	Sale	305.57	500	152,783	5,423	Dec 22 09:00 PM
Preston Jack M	CHIEF FINANCIAL OFFICER	Dec 15 '23	Option Exercise	61.30	33,399	2,047,359	33,400	Dec 18 09:15 PM
Preston Jack M	CHIEF FINANCIAL OFFICER	Dec 15 '23	Sale	312.09	33,399	10,423,497	1	Dec 18 09:15 PM
Chaya Eri	SEE REMARKS	Dec 14 '23	Option Exercise	61.30	50,000	3,065,000	50,000	Dec 18 09:15 PM
Chaya Eri	SEE REMARKS	Dec 14 '23	Sale	290.00	50,000	14,500,000	0	Dec 18 09:15 PM
ALBERINI CARLOS	Director	Sep 12 '23	Sale	310.42	25,000	7,760,462	21,916	Sep 13 09:00 PM
Lee Edward T	SEE REMARKS	Jun 27 '23	Option Exercise	116.56	1,400	163,178	3,624	Jun 28 09:00 PM
DEMILIO MARK S	Director	Jun 27 '23	Sale	305.24	2,000	610,473	14,480	Jun 28 09:00 PM
Lee Edward T	SEE REMARKS	Jun 27 '23	Sale	300.00	1,400	420,000	2,624	Jun 28 09:00 PM
Belling Keith	Director	Jun 14 '23	Sale	279.99	1,000	279,986	5,500	Jun 15 09:00 PM
DEMILIO MARK S	Director	Jun 06 '23	Sale	267.35	2,000	534,700	16,480	Jun 07 09:00 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

FOLD

Amicus Therapeutics Inc

RH

RH

Upgrade your FINVIZ experience